loading page

Impact of pharmacological Interventions on fertility outcomes in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials
  • +5
  • MOHAMMED ABDALLA,
  • Najeeb Shah ,
  • Harshal Deshmukh,
  • Amirhossein Sahebkar ,
  • Linda Östlundh,
  • Rami Al-Rifai,
  • Stephen Atkin ,
  • Thozhukat Sathyapalan
MOHAMMED ABDALLA
University of Hull

Corresponding Author:[email protected]

Author Profile
Najeeb Shah
University of Hull
Author Profile
Harshal Deshmukh
Hull University Teaching Hospitals NHS Trust
Author Profile
Amirhossein Sahebkar
Mashhad University of Medical Sciences
Author Profile
Linda Östlundh
United Arab Emirates University
Author Profile
Rami Al-Rifai
United Arab Emirates University
Author Profile
Stephen Atkin
Royal College of Surgeons in Ireland and Medical University of Bahrain
Author Profile
Thozhukat Sathyapalan
University of Hull
Author Profile

Abstract

Background: Polycystic ovary syndrome (PCOS) is an endocrine condition associated with sub-fertility, infertility and poor reproductive outcomes. Objectives: To review the effectiveness of different pharmacological interventions on fertility outcomes in women with PCOS. Search Strategy: We searched PubMed, MEDLINE, Scopus, Embase, Cochrane Library, Web of Science in April 2020 and updated the search in PubMed March 2021. Selection Criteria: Two independent reviewers selected studies, and only randomised controlled trials (RCTs) were included. Data Collection and Analysis: Thirty-four RCTs that met the eligibility criteria were used to calculate odds ratios (OR) and the 95% confidence interval (95% CI) using the random effect model. Main Results: There was a significant increase in pregnancy rate with follicular stimulating hormone (FSH) vs clomiphene citrate (CC)+ metformin (Odd Ratio(OR):4.08; 95%CI:1.12-14.83,I²=79%), Letrozole vs CC (OR: 1.58; 95%CI: 1.34-1.86, I²= 0%), metformin vs placebo(OR: 3.00; 95%CI: 1.95-4.59, I²= 0%) and with CC+ metformin vs CC (OR: 1.48; 95%CI: 1.02-2.16, I²= 39%). There were significant increases in ovulation rate with CC+ metformin vs FSH (OR: 0.09; 95%CI: 0.02-0.37, I² = 75%), CC+ metformin vs CC (OR: 2.04; 95%CI: 1.35-3.08, I² = 63%) and with Letrozole vs CC (OR: 1.60; 95%CI: 1.02-2.52, I²= 88%). A significant increase in live birth with Letrozole vs CC (OR: 1.63; 95%CI: 1.21-2.21, I² = 0%) was observed. Conclusions: CC, letrozole alone or either added to metformin, were associated with a significant increase in the pregnancy rate, ovulation rate, and live birth rate in women with PCOS. Funding: No fund for the review.